Compare IDEXX Laboratories, Inc. (IDXX) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs VanEck Rare Earth/Strategic Metals — how do they compare? IDEXX Laboratories, Inc. trades at $551.53 (market cap $44.48B), while VanEck Rare Earth/Strategic Metals trades at $71.97. The key difference: VanEck Rare Earth/Strategic Metals is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | REMX | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $766.68 | $109.53 |
52-Week Low | $520.87 | $49.22 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
REMX (VanEck Rare Earth and Strategic Metals ETF) trades at $69.85, down 3.88% over the past day amid a bearish technical signal, with moving averages indicating strong selling pressure. The ETF provides exposure to 38 global rare earth and strategic metals companies, heavily weighted toward China, and exhibits high volatility around 50% annually. Recent news highlights rare earth metals' strategic importance in technology and energy security, with China's export controls and geopolitical tensions influencing supply dynamics.
Outlook remains speculative due to geopolitical risks and commodity price swings, offering growth potential from the reshoring of critical mineral supply chains. Key risks include China concentration, regulatory changes, and high ETF turnover, making it suitable only for aggressive portfolios as a satellite holding. Investors should weigh supply chain diversification trends against volatility and liquidity concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
